Functional interaction of g protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP)

被引:21
作者
Born, W
Muff, R
Fischer, JA
机构
[1] Univ Zurich, Res Lab Calcium Metabol, Dept Orthoped Surg, Klin Balgrist, CH-8008 Zurich, Switzerland
[2] Univ Zurich, Res Lab Calcium Metabol, Dept Med, Klin Balgrist, CH-8008 Zurich, Switzerland
关键词
adrenomedullin; amylin; calcitonin; calcitonin gene-related peptide; G protein; heterodimer; receptor; receptor-activity-modifying protein;
D O I
10.1002/jemt.10051
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Adrenomedullin (AM), alpha- and beta-calcitonin gene-related peptide (CGRP), calcitonin (CT), and amylin are homologous polypeptides with overlapping biological actions such as vasodilatation and inhibition of bone resorption. They are brought about through receptors that include the CT receptor (CTR) and an initially orphan CT receptor-like receptor (CRLR) in association with receptor-activity-modifying proteins (RAMP)l, -2, and -3. Co-expression of CRLR with RAMP1 or -2 revealed CGRP or AM receptors, respectively. The CTR interacts with CT and does not require a known RAMP for functional expression. The same CTR is a CGRP/amylin or an amylin receptor upon co-expression with RAMP1 or -3, respectively. Interactions between CRLR and RAMP are thought to be required for their delivery to the cell surface. There, heterodimeric complexes between CRLR or CTR and the corresponding RAMP reveal high-affinity receptors for AM, CGRP, and amylin. Here we review the current knowledge on interactions of G protein-coupled receptors with defined associated proteins. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:14 / 22
页数:9
相关论文
共 85 条
[11]   Calcitonin gene-related peptide: Vasoactive effects and potential therapeutic role [J].
Brain, SD ;
Cambridge, H .
GENERAL PHARMACOLOGY, 1996, 27 (04) :607-611
[12]   A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1 [J].
Bühlmann, N ;
Leuthäuser, K ;
Muff, R ;
Fischer, JA ;
Born, W .
ENDOCRINOLOGY, 1999, 140 (06) :2883-2890
[13]   Glycosylation of the calcitonin receptor-like receptor at Asn60 or Asn112 is important for cell surface expression [J].
Bühlmann, N ;
Aldecoa, A ;
Leuthäuser, K ;
Gujer, R ;
Muff, R ;
Fischer, JA ;
Born, W .
FEBS LETTERS, 2000, 486 (03) :320-324
[14]   CGRP and adrenomedullin binding correlates with transcript levels for Calcitonin Receptor-Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) in rat tissues [J].
Chakravarty, P ;
Suthar, TP ;
Coppock, HA ;
Nicholl, CG ;
Bloom, SR ;
Legon, S ;
Smith, DM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :189-195
[15]   IDENTIFICATION OF A 7 TRANSMEMBRANE HELIX RECEPTOR FOR CORTICOTROPIN-RELEASING FACTOR AND SAUVAGINE IN MAMMALIAN BRAIN [J].
CHANG, CP ;
PEARSE, RV ;
OCONNELL, S ;
ROSENFELD, MG .
NEURON, 1993, 11 (06) :1187-1195
[16]   Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors [J].
Chen, WJ ;
Armour, S ;
Way, J ;
Chen, G ;
Watson, C ;
Irving, P ;
Cobb, J ;
Kadwell, S ;
Beaumont, K ;
Rimele, T ;
Kenakin, T .
MOLECULAR PHARMACOLOGY, 1997, 52 (06) :1164-1175
[17]   Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product [J].
Christopoulos, G ;
Perry, KJ ;
Morfis, M ;
Tilakaratne, N ;
Gao, YY ;
Fraser, NJ ;
Main, MJ ;
Foord, SM ;
Sexton, PM .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :235-242
[18]   AMYLIN FOUND IN AMYLOID DEPOSITS IN HUMAN TYPE-2 DIABETES-MELLITUS MAY BE A HORMONE THAT REGULATES GLYCOGEN-METABOLISM IN SKELETAL-MUSCLE [J].
COOPER, GJS ;
LEIGHTON, B ;
DIMITRIADIS, GD ;
PARRYBILLINGS, M ;
KOWALCHUK, JM ;
HOWLAND, K ;
ROTHBARD, JB ;
WILLIS, AC ;
REID, KBM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (20) :7763-7766
[19]   PURIFICATION AND CHARACTERIZATION OF A PEPTIDE FROM AMYLOID-RICH PANCREASES OF TYPE-2 DIABETIC-PATIENTS [J].
COOPER, GJS ;
WILLIS, AC ;
CLARK, A ;
TURNER, RC ;
SIM, RB ;
REID, KBM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8628-8632
[20]  
Copp D.H., 1961, P CAN FED BIOL SCI, V4, P17